What Happens When You Stop a GLP-1?

Food noise, appetite, and cravings often return — and imaging suggests the quiet was being maintained, not permanently reset. What the evidence says about rebound and persistence.

The short answer

For many people, the changes fade after stopping. Appetite and food noise tend to return, weight regain is common, and the timing varies widely from person to person. The honest summary is that these medications appear to manage a process rather than cure it — which reframes stopping as a transition to plan for, not a failure.

What returns, and roughly when

Semaglutide and tirzepatide clear the body over about four to five weeks after the last dose, so effects taper rather than vanish overnight. Surveys of people who stop report food noise coming back for a majority, sometimes alongside a rush of old eating patterns and anxiety when stopping is abrupt. There is no established timeline predicting exactly when appetite returns; individual responses differ enough that a fixed schedule would be misleading.

The imaging clue

A brain-imaging study reported in late 2025 followed people on tirzepatide and found that quieted activity in food-preoccupation regions reappeared after roughly five months, along with the return of intense food noise. The interpretation offered was that the drug's effect on loss-of-control eating was being actively maintained, and that the underlying patterns resurfaced when that maintenance stopped. This is a small study, but it fits what people describe and gives the rebound a mechanism rather than only anecdotes.

Weight regain in context

Among people who discontinued semaglutide without restarting, regaining a large share of lost weight within a year has been repeatedly observed. This is not evidence of personal failure; it is what you would expect if the medication was managing appetite signaling that returns once the drug is gone. Framing regain as backsliding misreads the biology and adds shame to an already hard transition.

What this means now

Stopping is a medical decision that benefits from a plan and support, not an abrupt exit. If you are considering stopping — for cost, side effects, pregnancy, or any reason — that conversation belongs with a qualified clinician who can discuss tapering and what to expect. Our survey asks specifically about what returned and how quickly, because the after-stopping experience is one of the least documented and most important parts of this whole picture.